Glycan News and Research

RSS
Cryptic pocket on the surface of SARS-CoV-2 may be a promising treatment target

Cryptic pocket on the surface of SARS-CoV-2 may be a promising treatment target

Could in vitro glycoengineering help produce better SARS-CoV-2 spike candidates for vaccine research?

Could in vitro glycoengineering help produce better SARS-CoV-2 spike candidates for vaccine research?

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

Scientists illuminate how some antibodies can effectively disable ebolaviruses

Scientists illuminate how some antibodies can effectively disable ebolaviruses

The role and ancestry of the SARS-CoV-2 spike protein glycan shield

The role and ancestry of the SARS-CoV-2 spike protein glycan shield

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

CAL20.C SARS-CoV-2 variant skyrocketing in California evades host immune response

CAL20.C SARS-CoV-2 variant skyrocketing in California evades host immune response

Glycans influence SARS-CoV-2 spike–ACE2 binding affinity, finds study

Glycans influence SARS-CoV-2 spike–ACE2 binding affinity, finds study

Glycans play a key role in COVID-19 infection, shows study

Glycans play a key role in COVID-19 infection, shows study

Engineering immunogens to focus immune response to SARS-CoV-2

Engineering immunogens to focus immune response to SARS-CoV-2

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Researchers present fragment-based computational design of antibodies that target structured epitopes

Researchers present fragment-based computational design of antibodies that target structured epitopes

Researchers study how glycans activate SARS-CoV-2

Researchers study how glycans activate SARS-CoV-2

Researchers identify a new mechanism underlying atherosclerosis

Researchers identify a new mechanism underlying atherosclerosis

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Study provides new information about the structure of prion proteins

Study provides new information about the structure of prion proteins